Literature DB >> 7012518

Role of ribonucleotide reductase in expression in the neoplastic program.

E Takeda, G Weber.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 7012518     DOI： 10.1016/0024-3205(81)90746-3

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  19 in total

1.  Expression of key enzymes of purine and pyrimidine metabolism in a hepatocyte-derived cell line at different phases of the growth cycle.

Authors:  D Mayer; Y Natsumeda; T Ikegami; M Faderan; M Lui; J Emrani; M Reardon; E Oláh; G Weber
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

Review 2.  Metabolic genes in cancer: their roles in tumor progression and clinical implications.

Authors:  Eiji Furuta; Hiroshi Okuda; Aya Kobayashi; Kounosuke Watabe
Journal:  Biochim Biophys Acta       Date:  2010-02-01

3.  Phase I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer.

Authors:  Charles A Kunos; Steven Waggoner; Vivian von Gruenigen; Elisa Eldermire; John Pink; Afshin Dowlati; Timothy J Kinsella
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

4.  Lack of correlation between deoxyribonucleotide pool sizes, spontaneous mutation rates and malignant potential in Chinese hamster ovary cells.

Authors:  A Y Tagger; J E Damen; A H Greenberg; J A Wright
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

5.  Identification of the di-pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti-tumour agents.

Authors:  Erika M Becker; David B Lovejoy; Judith M Greer; Ralph Watts; Des R Richardson
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

6.  Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase.

Authors:  T Szekeres; K Gharehbaghi; M Fritzer; M Woody; A Srivastava; B van't Riet; H N Jayaram; H L Elford
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  Modulating radiation resistance by inhibiting ribonucleotide reductase in cancers with virally or mutationally silenced p53 protein.

Authors:  Charles A Kunos; Song-mao Chiu; John Pink; Timothy J Kinsella
Journal:  Radiat Res       Date:  2009-12       Impact factor: 2.841

8.  Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells.

Authors:  Astrid Bernhaus; Maria Ozsvar-Kozma; Philipp Saiko; Margit Jaschke; Andreas Lackner; Michael Grusch; Zsuzsanna Horvath; Sibylle Madlener; Georg Krupitza; Norbert Handler; Thomas Erker; Walter Jaeger; Monika Fritzer-Szekeres; Thomas Szekeres
Journal:  Invest New Drugs       Date:  2008-10-08       Impact factor: 3.850

9.  Regulation of ribonucleotide reductase activity in mammalian cells.

Authors:  J G Cory; A Sato
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

10.  Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells.

Authors:  Philipp Saiko; Geraldine Graser; Benedikt Giessrigl; Marie-Thérèse Steinmann; Heike Schuster; Andreas Lackner; Michael Grusch; Georg Krupitza; Walter Jaeger; Venkateswarlu Somepalli; Trimurtulu Golakoti; Monika Fritzer-Szekeres; Thomas Szekeres
Journal:  Invest New Drugs       Date:  2013-08-14       Impact factor: 3.850
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.